Medical practice; ensure that stem cell therapies are used to advance medical treatments and improve patient outcomes in an ethical manner that does not involve stem cells derived from aborted fetuses

Summary

The bill lets doctors, physician assistants and nurse practitioners offer stem‑cell therapies that are not FDA‑approved, as long as the cells come from sources like umbilical cords and not aborted fetuses. It requires written patient consent, a clear advertising notice, and that the cells be obtained from FDA‑registered or accredited facilities. Violations can lead to professional discipline, but the law does not restrict stem‑cell research.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share